These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24251757)

  • 1. The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease?
    Degenhardt L; Whiteford H; Hall WD
    Drug Alcohol Rev; 2014 Jan; 33(1):4-12. PubMed ID: 24251757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the burden of disease attributable to illicit drug use and mental disorders: what is 'Global Burden of Disease 2005' and why does it matter?
    Degenhardt L; Whiteford H; Hall W; Vos T
    Addiction; 2009 Sep; 104(9):1466-71. PubMed ID: 19686517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?
    Whiteford HA; Ferrari AJ; Baxter AJ; Charlson FJ; Degenhardt L
    Curr Opin Psychiatry; 2013 Jul; 26(4):376-83. PubMed ID: 23689547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of illicit drug use and dependence, and their contribution to the global burden of disease.
    Degenhardt L; Hall W
    Lancet; 2012 Jan; 379(9810):55-70. PubMed ID: 22225671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010.
    Degenhardt L; Baxter AJ; Lee YY; Hall W; Sara GE; Johns N; Flaxman A; Whiteford HA; Vos T
    Drug Alcohol Depend; 2014 Apr; 137():36-47. PubMed ID: 24559607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews.
    Degenhardt L; Bucello C; Calabria B; Nelson P; Roberts A; Hall W; Lynskey M; Wiessing L; ; Mora ME; Clark N; Thomas J; Briegleb C; McLaren J
    Drug Alcohol Depend; 2011 Sep; 117(2-3):85-101. PubMed ID: 21377813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use.
    Chisholm D; Doran C; Shibuya K; Rehm J
    Drug Alcohol Rev; 2006 Nov; 25(6):553-65. PubMed ID: 17132573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global burden of disease from alcohol, illicit drugs and tobacco.
    Rehm J; Taylor B; Room R
    Drug Alcohol Rev; 2006 Nov; 25(6):503-13. PubMed ID: 17132570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increasing global health priority of substance use in young people.
    Degenhardt L; Stockings E; Patton G; Hall WD; Lynskey M
    Lancet Psychiatry; 2016 Mar; 3(3):251-64. PubMed ID: 26905480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the burden of disease attributable to alcohol use in South Africa in 2000.
    Schneider M; Norman R; Parry C; Bradshaw D; Plüddemann A;
    S Afr Med J; 2007 Aug; 97(8 Pt 2):664-72. PubMed ID: 17952223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study.
    Smith E; Hoy DG; Cross M; Vos T; Naghavi M; Buchbinder R; Woolf AD; March L
    Ann Rheum Dis; 2014 Aug; 73(8):1462-9. PubMed ID: 24590181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global burden of gout: estimates from the Global Burden of Disease 2010 study.
    Smith E; Hoy D; Cross M; Merriman TR; Vos T; Buchbinder R; Woolf A; March L
    Ann Rheum Dis; 2014 Aug; 73(8):1470-6. PubMed ID: 24590182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of occupational risks to the global burden of disease: summary and next steps.
    Fingerhut M; Nelson DI; Driscoll T; Concha-Barrientos M; Steenland K; Punnett L; Prüss-Ustün A; Leigh J; Corvalan C; Eijkemans G; Takala J
    Med Lav; 2006; 97(2):313-21. PubMed ID: 17017364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood sexual abuse and risks for licit and illicit drug-related outcomes: a twin study.
    Nelson EC; Heath AC; Lynskey MT; Bucholz KK; Madden PA; Statham DJ; Martin NG
    Psychol Med; 2006 Oct; 36(10):1473-83. PubMed ID: 16854248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
    Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
    Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global burden of disease (GBD) for hepatitis C.
    Global Burden Of Hepatitis C Working Group
    J Clin Pharmacol; 2004 Jan; 44(1):20-9. PubMed ID: 14681338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the impact of unsafe water, sanitation and hygiene on the global burden of disease: evolving and alternative methods.
    Clasen T; Pruss-Ustun A; Mathers CD; Cumming O; Cairncross S; Colford JM
    Trop Med Int Health; 2014 Aug; 19(8):884-93. PubMed ID: 24909205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of substance use in a representative sample of 18-year-old males.
    Kapusta ND; Ramskogler K; Hertling I; Schmid R; Dvorak A; Walter H; Lesch OM
    Alcohol Alcohol; 2006; 41(2):188-92. PubMed ID: 16322099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NASBOD 2013: design, definitions, and metrics.
    Farzadfar F; Delavari A; Malekzadeh R; Mesdaghinia A; Jamshidi HR; Sayyari A; Larijani B
    Arch Iran Med; 2014 Jan; 17(1):7-15. PubMed ID: 24444059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Burden Of Disease Studies: Implications For Mental And Substance Use Disorders.
    Whiteford H; Ferrari A; Degenhardt L
    Health Aff (Millwood); 2016 Jun; 35(6):1114-20. PubMed ID: 27269030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.